Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 3793781, 12 pages
http://dx.doi.org/10.1155/2016/3793781
Research Article

Serotonin- and Dopamine-Related Gene Expression in db/db Mice Islets and in MIN6 β-Cells Treated with Palmitate and Oleate

1Departamento de Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile
2Facultad de Medicina, Universidad de los Andes, 7620001 Santiago, Chile
3UDA-Ciencias de la Salud, Carrera de Nutrición y Dietética, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile
4Departamento de Nutrición, Facultad de Medicina, Universidad de Chile, 7550367 Santiago, Chile
5Laboratorio de Hemostasia, Escuela de Medicina, Pontificia Universidad Católica de Chile, 8331150 Santiago, Chile

Received 27 January 2016; Revised 26 April 2016; Accepted 10 May 2016

Academic Editor: Andrea Tura

Copyright © 2016 L. R. Cataldo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Weyer, C. Bogardus, D. M. Mott, and R. E. Pratley, “The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus,” The Journal of Clinical Investigation, vol. 104, no. 6, pp. 787–794, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Sumara, O. Sumara, J. K. Kim, and G. Karsenty, “Gut-derived serotonin is a multifunctional determinant to fasting adaptation,” Cell Metabolism, vol. 16, no. 5, pp. 588–600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Taggart and M. Carruthers, “Endogenous hyperlipidaemia induced by emotional stress of racing driving,” The Lancet, vol. 297, no. 7695, pp. 363–366, 1971. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Boden, “Free fatty acids (FFA), a link between obesity and insulin resistance,” Frontiers in Bioscience, vol. 3, pp. d169–d175, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. McGarry and R. L. Dobbins, “Fatty acids, lipotoxicity and insulin secretion,” Diabetologia, vol. 42, no. 2, pp. 128–138, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. H. Wilding, “The importance of free fatty acids in the development of Type 2 diabetes,” Diabetic Medicine, vol. 24, no. 9, pp. 934–945, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Kristinsson, P. Bergsten, and E. Sargsyan, “Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1853, no. 12, pp. 3248–3257, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Sako and V. E. Grill, “A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation,” Endocrinology, vol. 127, no. 4, pp. 1580–1589, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-P. Zhou and V. E. Grill, “Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle,” Journal of Clinical Investigation, vol. 93, no. 2, pp. 870–876, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-P. Zhou and V. Grill, “Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 5, pp. 1584–1590, 1995. View at Google Scholar · View at Scopus
  11. G. Patanè, M. Anello, S. Piro, R. Vigneri, F. Purrello, and A. M. Rabuazzo, “Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition,” Diabetes, vol. 51, no. 9, pp. 2749–2756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Barradas, D. S. Gill, V. A. Fonseca, D. P. Mikhailidis, and P. Dandona, “Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease,” European Journal of Clinical Investigation, vol. 18, no. 4, pp. 399–404, 1988. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Hara, Y. Hirowatari, Y. Shimura, and H. Takahashi, “Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease,” Diabetes Research and Clinical Practice, vol. 94, no. 2, pp. 167–171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Innis and S. de la Presa Owens, “Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain,” Journal of Nutrition, vol. 131, no. 1, pp. 118–122, 2001. View at Google Scholar · View at Scopus
  15. Q. Zhang, Y. Zhu, W. Zhou, L. Gao, L. Yuan, and X. Han, “Serotonin receptor 2C and insulin secretion,” PLoS ONE, vol. 8, no. 1, Article ID e54250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Ganic, J. K. Johansson, H. Bennet, M. Fex, and I. Artner, “Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes,” Biochemical and Biophysical Research Communications, vol. 468, no. 4, pp. 629–635, 2015. View at Publisher · View at Google Scholar
  17. G. Eisenhofer, Å. Aneman, P. Friberg et al., “Substantial production of dopamine in the human gastrointestinal tract,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 11, pp. 3864–3871, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ustione and D. W. Piston, “Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca2+] oscillations,” Molecular Endocrinology, vol. 26, no. 11, pp. 1928–1940, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Ustione, D. W. Piston, and P. E. Harris, “Minireview: dopaminergic regulation of insulin secretion from the pancreatic islet,” Molecular Endocrinology, vol. 27, no. 8, pp. 1198–1207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. E. Richmond, A. Codignola, I. M. Cooke, and E. Sher, “Calcium and barium dependent exocytosis from the rat insulinoma cell line RINm5F assayed using membrane capacitance measurements and serotonin release,” Pflügers Archiv, vol. 432, no. 2, pp. 258–269, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Ekholm, L. E. Ericson, and I. Lundquist, “Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography,” Diabetologia, vol. 7, no. 5, pp. 339–348, 1971. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Gylfe, “Association between 5-hydroxytryptamine release and insulin secretion,” Journal of Endocrinology, vol. 78, no. 2, pp. 239–248, 1978. View at Publisher · View at Google Scholar · View at Scopus
  23. I. García-Tornadú, A. M. Ornstein, A. Chamson-Reig et al., “Disruption of the dopamine D2 receptor impairs insulin secretion and causes glucose intolerance,” Endocrinology, vol. 151, no. 4, pp. 1441–1450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. R. Cataldo, V. A. Cortés, J. E. Galgani, P. R. Olmos, and J. L. Santos, “Role of peripheral serotonin in the insulin secretion and glucose homeostasis,” Nutricion Hospitalaria, vol. 30, no. 3, pp. 498–508, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Ohara-Imaizumi, H. Kim, M. Yoshida et al., “Serotonin regulates glucose-stimulated insulin secretion from pancreatic β cells during pregnancy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 48, pp. 19420–19425, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Kim, C. M. Oh, M. Ohara-Imaizumi et al., “Functional role of serotonin in insulin secretion in a diet-induced insulin-resistant state,” Endocrinology, vol. 156, no. 2, pp. 444–452, 2015. View at Publisher · View at Google Scholar
  27. N. Simpson, A. Maffei, M. Freeby et al., “Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro,” Molecular Endocrinology, vol. 26, no. 10, pp. 1757–1772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nocito, F. Dahm, W. Jochum et al., “Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis,” Gastroenterology, vol. 133, no. 2, pp. 608–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. J. Rosen, “Serotonin rising—the bone, brain, bowel connection,” The New England Journal of Medicine, vol. 360, no. 10, pp. 957–959, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Amireault, D. Sibon, and F. Coîté, “Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks,” ACS Chemical Neuroscience, vol. 4, no. 1, pp. 64–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Paulmann, M. Grohmann, J.-P. Voigt et al., “Intracellular serotonin modulates insulin secretion from pancreatic β-cells by protein serotonylation,” PLoS Biology, vol. 7, no. 10, Article ID e1000229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. D. J. Walther, J.-U. Peter, S. Bashammakh et al., “Synthesis of serotonin by a second tryptophan hydroxylase isoform,” Science, vol. 299, no. 5603, article 76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Ohta, Y. Kosaka, N. Kishimoto et al., “Convergence of the insulin and serotonin programs in the pancreatic β-cell,” Diabetes, vol. 60, no. 12, pp. 3208–3216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Sommerweiss, T. Gorski, S. Richter, A. Garten, and W. Kiess, “Oleate rescues INS-1E β-cells from palmitate-induced apoptosis by preventing activation of the unfolded protein response,” Biochemical and Biophysical Research Communications, vol. 441, no. 4, pp. 770–776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. E. G. Bligh and W. J. Dyer, “A rapid method of total lipid extraction and purification,” Canadian Journal of Biochemistry and Physiology, vol. 37, no. 8, pp. 911–917, 1959. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Valenzuela, C. Barrera, A. Espinosa, P. Llanos, P. Orellana, and L. A. Videla, “Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: relation to LCPUFA depletion in liver and extrahepatic tissues,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 98, pp. 7–14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. R. N. Kulkarni, J. N. Winnay, M. Daniels et al., “Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines,” The Journal of Clinical Investigation, vol. 104, no. 12, pp. R69–R75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. D. S. Li, Y. Yuan, H. Tu, Q. Liang, and L. Dai, “A protocol for islet isolation from mouse pancreas,” Nature Protocols, vol. 4, no. 11, pp. 1649–1652, 2009. View at Publisher · View at Google Scholar
  39. A. M. Kumar, M. Kumar, K. Deepika, J. B. Fernandez, and C. Eisdorfer, “A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma,” Life Sciences, vol. 47, no. 19, pp. 1751–1759, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. L. S. Dalbøge, D. L. Almholt, T. S. Neerup et al., “Characterisation of age-dependent Beta cell dynamics in the male db/db mice,” PLoS ONE, vol. 8, no. 12, article e82813, 2013. View at Publisher · View at Google Scholar
  41. O. Berglund, B. J. Frankel, and B. Hellman, “Development of the insulin secretory defect in genetically diabetic (db/db) mouse,” Acta Endocrinologica, vol. 87, no. 3, pp. 543–551, 1978. View at Google Scholar · View at Scopus
  42. O. H. Do, J. T. Low, H. Y. Gaisano, and P. Thorn, “The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells,” Diabetologia, vol. 57, no. 7, pp. 1400–1409, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Duan and J. Wang, “Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3,” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 3, pp. 743–753, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Itoh, Y. Kawamata, M. Harada et al., “Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40,” Nature, vol. 422, no. 6928, pp. 173–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Maestre, J. Jordán, S. Calvo et al., “Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the β-cell line INS-1,” Endocrinology, vol. 144, no. 1, pp. 335–345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Brun, P. Scarcia, N. Li et al., “Changes in mitochondrial carriers exhibit stress-specific signatures in INS-1E β-cells exposed to glucose versus fatty acids,” PLoS ONE, vol. 8, no. 12, Article ID e82364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. C.-Y. Zhang, G. Baffy, P. Perret et al., “Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes,” Cell, vol. 105, no. 6, pp. 745–755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. J. C. Yoon, G. Xu, J. T. Deeney et al., “Suppression of β cell energy metabolism and insulin release by PGC-1α,” Developmental Cell, vol. 5, no. 1, pp. 73–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. M. C. Åkerfeldt and D. R. Laybutt, “Inhibition of Id1 augments insulin secretion and protects against high-fat diet-induced glucose intolerance,” Diabetes, vol. 60, no. 10, pp. 2506–2514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Quan, L. Zhang, Y. Li, and C. Liang, “TCF2 attenuates FFA-induced damage in islet β-cells by regulating production of insulin and ROS,” International Journal of Molecular Sciences, vol. 15, no. 8, pp. 13317–13332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Affourtit and M. D. Brand, “Uncoupling protein-2 contributes significantly to high mitochondrial proton leak in INS-1E insulinoma cells and attenuates glucose-stimulated insulin secretion,” Biochemical Journal, vol. 409, no. 1, pp. 199–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Barlow and C. Affourtit, “Novel insights into pancreatic β-cell glucolipotoxicity from real-time functional analysis of mitochondrial energy metabolism in INS-1E insulinoma cells,” Biochemical Journal, vol. 456, no. 3, pp. 417–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. Y.-H. Huang, A. Ito, and R. Arai, “Immunohistochemical localization of monoamine oxidase type B in pancreatic islets of the rat,” Journal of Histochemistry and Cytochemistry, vol. 53, no. 9, pp. 1149–1158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Aleyassine and R. J. Gardiner, “Dual action of antidepressant drugs (MAO inhibitors) on insulin release,” Endocrinology, vol. 96, no. 3, pp. 702–710, 1975. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Lundquist, R. Ekholm, and L. E. Ericson, “Monoamines in the pancreatic islets of the mouse-5-Hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors,” Diabetologia, vol. 7, no. 6, pp. 414–422, 1971. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Andersohn, R. Schade, S. Suissa, and E. Garbe, “Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus,” American Journal of Psychiatry, vol. 166, no. 5, pp. 591–598, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. El-Merahbi, M. Löffler, A. Mayer, and G. Sumara, “The roles of peripheral serotonin in metabolic homeostasis,” FEBS Letters, vol. 589, no. 15, Article ID 37210, pp. 1728–1734, 2015. View at Publisher · View at Google Scholar · View at Scopus